![A healthy 80-year old man had, during the last six month period, experienced a 5 kg non-intended weight loss, malaise, coughing, and extreme fatigue. Before the symptoms started, he was physically active and bicycled 20--40 km and rowed 10--15 km per week. As symptoms progressed, muscle tenderness in the shoulder and hip regions made exercising impossible. No morning stiffness of the joints was experienced. Blood tests showed a mild normocytic normochromic anemia, elevated C-reactive protein (100 mg/L), and erythrocyte sedimentation rate (88 mm/h). PMR was suspected, but malignancy was a differential diagnosis. A total of 3.85 MBq/kg ^18^F-FDG was administrated an hour before a whole body PET/CT scan was performed. (**A**) Frontal PET MIP showed highly increased ^18^F-FDG uptake diffusely around shoulder (yellow arrows) and hip joints (red arrows), indicating bursitis, but also in the wall of the large arteries (green arrows), indicating synchronic LVV confirmed on (**B**) sagittal fused PET/CT of the aorta (green arrow). The LVV aorta and its major branches are affected, but the vertebral (green arrows) and maxillary (white arrow, right side shown) arteries could also be involved, (**C**) axial fused PET/CT. Notably, the ^18^F-FDG uptake in the affected arteries (not quantitatively shown) was more than two times the uptake in the liver, which has been shown to accurately indicate LVV on PET/CT \[[@B1-diagnostics-08-00027],[@B2-diagnostics-08-00027],[@B3-diagnostics-08-00027],[@B4-diagnostics-08-00027]\].](diagnostics-08-00027-g001){#diagnostics-08-00027-f001}

![Visually measuring the ^18^F-FDG uptake in nine anatomical sites when evaluating the PET/CT scan for the diagnosis of PMR has been suggested \[[@B5-diagnostics-08-00027],[@B6-diagnostics-08-00027]\]. These sites include: acromioclavicular joints (**A**) axial fused PET/CT (yellow arrow, left side shown), the high ^18^F-FDG uptake in the axillary arteries indicates LVV (green arrows); shoulder joints (**B**) axial fused PET/CT (yellow arrows), LVV in axillary arteries (green arrows); sternoclavicular joints (**C**) axial fused PET/CT (yellow arrows), LVV in subclavian arteries (green arrows) and common carotid arteries (white arrows); hip joints (**D**) axial fused PET/CT (yellow arrow, left side shown) and greater trochanter (**D**) axial fused PET/CT (red arrow, right side shown); the two iliopectinal bursae (**E**) axial fused PET/CT (yellow arrow, right side shown), LVV in common femoral arteries (green arrows); two symphysis pubis enthesis (**F**) axial fused PET/CT (yellow arrows) and two ischial tuberosities (**F**) axial fused PET/CT (red arrows), LVV in superficial femoral arteries (green arrows) and right profound femoral artery (white arrow); and interspinous ligaments (**G**) axial fused PET/CT (yellow arrow), respectively. The specificity of ^18^F-FDG PET/CT in the diagnosis of PMR is 95% given that the ^18^F-FDG uptake is above the uptake in the liver in ≥6 anatomical sites \[[@B5-diagnostics-08-00027]\]. In our case, the ^18^F-FDG uptake met this criterion in all nine anatomical sites (not quantitatively shown). No malignancy was visualized. Based on the clinical information and the results of the ^18^F-FDG PET/CT, the patient was treated with 60 mg of Prednisolone resulting in the normalization of blood tests and rapid remission of symptoms. Our case shows that ^18^F-FDG PET/CT is a strong supportive imaging tool in the diagnosis of PMR and LVV. ^18^F-FDG PET/CT can be used where malignancy is a differential diagnosis, as proposed in the newest European League Against Rheumatism (EULAR) recommendations \[[@B7-diagnostics-08-00027]\].](diagnostics-08-00027-g002){#diagnostics-08-00027-f002}
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